A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : RBA / radiobinding assay

[Related PubMed/MEDLINE]
Total Number of Papers: 36
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   RBA  (>> Co-occurring Abbreviation)
Long Form:   radiobinding assay
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases. APS1, ECL, GADA, IA-2A, IAbs, T1D, TGA, TPOA, ZnT8A
2020 Islet autoantibodies in disease prediction and pathogenesis. ECL, IAbs, T1D
2020 Screening for autoantibody targets in post-vaccination narcolepsy using proteome arrays. FDR, HLA, NT1
2019 Determination of Autoantibodies to Transglutaminase by Electrochemiluminescence (ECL) Assay. ECL, TGA
2019 High-throughput multiplexed autoantibody detection to screen type 1 diabetes and multiple autoimmune diseases simultaneously. APS1, ECL, IAbs, T1D
2018 Electrochemiluminescence Assays for Human Islet Autoantibodies. BSA, ELISA, PBS, T1D
2016 High fasting serum insulin level due to autoantibody interference in insulin immunoassay discloses autoimmune insulin syndrome: a case report. GFC, IgG
2015 Antibodies to post-translationally modified insulin in type 1 diabetes. IAAs, oxPTM, oxPTM-INS
2015 Detection of Antibodies Directed to the N-Terminal Region of GAD Is Dependent on Assay Format and Contributes to Differences in the Specificity of GAD Autoantibody Assays for Type 1 Diabetes. GADAs
10  2015 Serological evaluation of possible exposure to Ljungan virus and related parechovirus in autoimmune (type 1) diabetes in children. HPeV, LV
11  2015 Zinc transporter 8 (ZnT8) autoantibody epitope specificity and affinity examined with recombinant ZnT8 variant proteins in specific ZnT8R and ZnT8W autoantibody-positive type 1 diabetes patients. aa, T1D, ZnT8, ZnT8A
12  2013 Antigenicity and epitope specificity of ZnT8 autoantibodies in type 1 diabetes. Ab, SNP, T1D, ZnT8
13  2013 Serological Proteome Analysis (SERPA) as a tool for the identification of new candidate autoantigens in type 1 diabetes. GDIbeta, SERPA, T1D
14  2012 Monitoring of anti-transglutaminase autoantibodies in pediatric celiac disease using a sensitive radiobinding assay. CD, ELISA, GFD, tTGA
15  2011 A novel triple mix radiobinding assay for the three ZnT8 (ZnT8-RWQ) autoantibody variants in children with newly diagnosed diabetes. BDD, T1D, ZnT8A
16  2011 Antibodies against insulin measured by electrochemiluminescence predicts insulitis severity and disease onset in non-obese diabetic mice and can distinguish human type 1 diabetes status. ECL, IA, IAA, NOD
17  2011 LIPS islet autoantibody assays in high-throughput format for DASP 2010. DASP, GAD, LIPS
18  2009 Low agreement between radio binding assays in analyzing glutamic acid decarboxylase (GAD65Ab) autoantibodies in patients classified with type 2 diabetes. ---
19  2008 Radiobinding assay for detecting autoantibodies to single epitopes. ---
20  2007 Time-resolved immunofluorometric dual-label assay for simultaneous detection of autoantibodies to GAD65 and IA-2 in children with type 1 diabetes. GADAs, GST, IA-2
21  2004 Evaluation of two nonisotopic immunoassays for determination of glutamic acid decarboxylase and tyrosine phosphatase autoantibodies in serum. IA-2As, TR-IFMA
22  2003 The use of phage display to distinguish insulin autoantibody (IAA) from insulin antibody (IA) idiotypes. IA, IAA, SD
23  2001 International Workshop on Lessons From Animal Models for Human Type 1 Diabetes: identification of insulin but not glutamic acid decarboxylase or IA-2 as specific autoantigens of humoral autoimmunity in nonobese diabetic mice. ELISA, GADA, IA-2A, IAA, NOD
24  2000 Frequency of glutamic acid decarboxylase autoantibodies in Mexican diabetic children. ---
25  1997 Clinical characteristics of patients with the initial diagnosis of NIDDM with positivity for antibodies to glutamic acid decarboxylase. BMI, GAD-Ab, ICA, IDDM, NIDDM
26  1997 Highly-sensitive and specific enzyme-linked immunosorbent assays for GAD65 autoantibodies using a thioredoxin-GAD65 fusion antigen. cELISA, ELISA, IDDM, p-ELISA, Trx-GAD65
27  1996 DELISA: sensitive nonisotopic assay for GAD65 autoantibodies, a key risk-assessment marker for insulin-dependent diabetes mellitus. bGAD65
28  1995 Disease sensitivity and specificity of 52 assays for glutamic acid decarboxylase antibodies. The Second International GADAB Workshop. EIP, ELISA, GAD-abs, IDDM, SMS
29  1994 Solid versus liquid phase assays in detection of insulin antibodies. Influence of iodination site on labelled insulin binding. ELISA, IAA
30  1994 [The characterization of 5-HT1A receptor in the central nervous system of the spontaneously hypertensive rats]. SHR
31  1994 [The measurement of insulin antibodies and insulin autoantibodies by enzyme-linked immunosorbent assay using recombinant human insulin antigen and its clinical application]. ELISA, IA, IDDM, NIDDM, OD
32  1993 Detection of autoantibodies against hGH in sera of idiopathic hypopituitary children. hGHAA
33  1993 Immunoelectron microscopy: a new method for detection of insulin antibodies. EIA, IEM
34  1993 Insulin autoantibodies and immune response to human insulin therapy in 24 type 1 (insulin-dependent) diabetic children: superiority of radio binding assay over solid phase assay. ELISA
35  1991 Superiority of radiobinding assay over ELISA for detection of IAAs in newly diagnosed type I diabetic children. ELISA, IAA
36  1984 In-vitro-derived bone marrow macrophages. Expression of Ia antigens during macrophage differentiation. BMDM, IIF, MLR